Company intelligence / Profile preview

Nofima

Tromsø, Troms og Finnmark, Norwaynofima.com ↗

Ownership: Private
Employees: ~397
Development stage: Other

Overview

Nofima conducts applied R&D across fisheries, aquaculture and the broader food industry. Recent results include successful laboratory-scale cultivation of bovine muscle cells (“cultivated meat”) using edible biomaterials and recombinant egg/milk protein production with yeast. The institute leads major EU-funded sustainability projects such as Millennial Salmon. No clinical drug development.

Therapeutic areas: Other
Modalities: Cell therapy (cultivated meat research)Recombinant protein (egg and milk proteins via yeast)Small molecule (food additives and nutrition research)Biologic (general food biotechnology applications)
Industry: Non-Drug Biotech

Partnerships

InnovaFeed (insect-based feed)Corbion Algae Ingredients (algae omega‑3s)Cargill (feed)SINTEF Ocean (R&D partner)Auchan Retailer Group

Beyond the preview

Go deeper on Nofima.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nofima.

Explore the full profile